Volume : 09, Issue : 08, August – 2022
Title:
24.FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLETS OF TERBUTALIINE SULFATE
Authors :
Nagdeve Dipali*, Patel Arun, Patel Shailendra, Shivavedi Naveen
Abstract :
The outcome of present work provides a concrete basis for development of fast dissolving tablets of Terbutaline sulphate. Various approaches explored in the present work can be applied to achieve quick disintegration, good mouth feel and adequate mechanical strength, which improve patient compliance. Further work can be focused on co processing of various diluents with superdisintegrant. Some herbal superdisintegrant in freeze dried form can be investigated to determine their effect on disintegration time and hardness. To evaluate the effects of fast dissolving tablets in stress conditions, pharmacokinetic study can be performed in diseased state, and to compare with the results obtained in non- diseased state. All the researchers working on Terbutaline sulphate concentrates their research on the disintegration behavior of the tablets using super disintegrants which does not full fill the basic requirements of the mouth dissolving tablets i.e. patient compliance. Industries who want to make a Terbutaline sulphate blindly incorporating insoluble taste masking resins, superdisintegrants for disintegration and trading as mouth dissolving tablet. Due to lots of limitations like hardness, mechanical strength, no ease of manufacturing and most important cost of manufacturing, that’s why, industries concentrate whole emphasis on the use of superdisintegrants and make researchers not to work on mouth dissolving tablets instead moves on to mouth disintegrating tablets. Thus we concentrate on formulating mouth dissolving tablets giving complete dissolution of the formulation with minimum residue.
KEYWORDS- Terbutaline sulphate, Migraine, Mouth Dissolving Tablet, Croscarmellose Sodium, Crospovidone, Superdisintegrants.
Cite This Article:
Please cite this article in press Nagdeve Dipali et al, Formulation And Evaluation Of Mouth Dissolving Tablets Of Terbutaliine Sulfate., Indo Am. J. P. Sci, 2022; 09(8).
,
Number of Downloads : 10
References:
1) Brahmankar D. M., Jaiswal S.B., Biopharmaceutics & Pharmaceutics, First Edition, 1995, 335.
2) Kalambate PK, Rawool CR, Srivastava AK. Fabrication of graphene nanosheet–multiwalled carbon nanotube–polyaniline modified carbon paste electrode for the simultaneous electrochemical determination of terbutaline sulphate and guaifenesin. New Journal of Chemistry. 2017;41(15):7061-72.
3) S. S. Biradar, S. T. Bhagavati and I. J. Kuppasad, Fast Dissolving Drug Delivery Systems: A Brief Overview, Internet J. Pharmacology, 2006, 4(2).
4) Kuccherkar B.S., Badhan A.C., Mahajan H.S., Mouth dissolving tablets: A novel drug delivery system, Phrma Times, 2003, 35, 3-10.
5) Kaushik D, Dureja H., Saini T. R., Mouth Dissolving Tablets: A review, Indian Drugs, 2004, 41(4), 187-193.
6) Amin A. F., Shah T. J., Bhadani M. N., Patel M. M., Emerging trends in orally disintegrating tablets, www.pharminfo.net, 2005.
7) Renon J. P. and Corveleyn S., Freeze-dried rapidly disintegrating tablets, US Patent No. 6,010,719, 2000.
8) Lailla J. K., Sharma A. H., Freeze-drying and its applications, Indian Drugs, 1993, 31, 503-513.
9) Seager H., Drug delivery products and zydis fast dissolving dosage form, J. Pharm. Phamacol., 1998, 50, 375-382.
10) Masaki K., Intrabuccaly disintegrating preparation and production, US Patent No. 5,466,464, 1995.
11) Pebley W. S., Jager N. E. and Thompson S. J., Rapidly disintegrating tablets, US Patent No. 5,298,261, 1994.
12) Allen L. V. and Wang B., Method of making a rapidly dissolving tablet, US Patent No. 5,635,210, 1997. Chapter-9 Bibliography Dept of Pharmaceutics 76 J. K. K. Nattaraja College of Pharmacy
13) Allen L. V. and Wang B., Process for making a particulate support matrix for making rapidly dissolving tablets, US Patent No. 5,587,180, 1996.
14) Heinmann H. and Rothe W., Preparation of porous tablets, US Patent No. 3,885,026, 1975.
15) Knistch K.W., Production of porous tablets, US Patent No. 4,134,843, 1979.
16) Roser B. J. and Blair J., Rapidly soluble oral dosage form, method of making same and composition, US Patent No. 5,762,961,1998.
17) Lachmann L., Liebermann H. A. and Kiang J.L., The theory and practice of Industrial Pharmacy, Third Edition, Varghese Publishing House, Bombay, 1998, 430-440.
18) Yarwood R. J., Kearny K. and Thomson A.R., Process for preparing solid dosage form for unpalatable pharmaceuticals, US Patent No. 5,738,875, 1998.
19) Parul B. Patel, Amit Chaudhary and G. D. Gupta, Fast Dissolving Drug Delivery Systems: An Update, www.pharmainfo.net, 2006.
20) Suresh B. Borsadia, David Halloran and James L. Osborne, Quick-dissolving films – A novel approach to drug delivery, www.drugdeliverytech.com, 2006.
21) Mishra B., Panigrahi D. and Baghel S., Mouth dissolving tablets: an overview of preparation techniques, evaluation and patented technologies, J. Pharm. Res., 2005, 4(3), 33-38.
22) Gregory G. K. E., Peach G. M. and Dumanya J. D., Method for producing fast dissolving dosage form, US Patent No. 4,371,561, 1983.
23) Mizumoto T., Masuda Y. and Fukui M., Intrabuccaly dissolving compressed moldings and production process, US Patent No. 5,576,014, 1996.
24) Robin H. Bogner and Meghan F. Wilkosz, Fast-Dissolving Tablets, www.uspharmacist.com, 2006.
25) Bhaskaran S. and Narmada, G. V., Orally disintegrating tablets, Indian Pharmacist, 2002, 1(2), 9-12. Chapter-9 Bibliography Dept of Pharmaceutics 77 J. K. K. Nattaraja College of Pharmacy
26) Tablets: Formulation of tablets/Disintegration, www.pharmpedia.com, 2006.
27) Shah U. and Augsburger L., Evaluation of the functional equivance of crospovidone NF from different sources: standard performance test, Pharm. Develop. Tech., 2001, 6, 419-430.
28) Swarbrick J., Boylan J., Encyclopedia of Pharmaceutical technology; 2nd Ed., Marcel Dekker, NY, 2002, 2623-2638.
29) Gohel M., Patel M., Amin A., Agrwal R., Dave R. and Bariya, N., Formulation design and optimization of mouth dissolve tablets of nimesulide using vaccum drying technique, AAPS Pharm SciTech, 2004, 5(3), 1-6
30) Omaima A. Sammour, Mohammed A. Hammad, Nagia A. Megrab and Ahmed S. Zidan., Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion, AAPS Pharm SciTech, 2006, 7 (2) Article 55.
31) Mutasem M. Rawas-Qalaji, F. Estelle R. Simons and Keith J. Simons., Fast- disintegrating sublingual tablets: effect of epinephrine load on tablet characteristics, AAPS Pharm SciTech, 2006, 7 (2) Article 41.
32) G. Abdelbary, P. Prinderre, C. Eouani, J. Joachim, J.P. Reynier and Ph. Piccerelle., The preparation of orally disintegrating tablets using a hydrophilic waxy binder, Int. J. Pharm., 2004, 278, 423–433.
33) Kei-ichi Koizumi, Yoshiteru Watanabe, Kumiko Morita, Naoki Utoguchi and Mitsuo Matsurnoto, New method of preparing high-porosity rapidly saliva soluble compressed tablets using mannitol with camphor, a subliming material, Int. J. Pharm., 1997, 152, 127-131.
34) Shawn A. Mitchell, Thomas D. Reynolds and Tina P. Dasbach, A compaction process to enhance dissolution of poorly water soluble drugs using hydroxypropyl methylcellulose, Int. J. Pharm., 2003, 250, 3-/11.
35) G. Abdelbary., C. Eouani, P. Prinderre, J. Joachim, Jp. Reynier and Ph. Piccerelle, Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration, Int. J. Pharm., 2005, 292, 29–41. Chapter-9 Bibliography Dept of Pharmaceutics 78 J. K. K. Nattaraja College of Pharmacy
36) Fukami J., Yonemochi E., Yoshihashi Y. and Terada K., Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose, Int. J. Pharm., 2006, 9, 101-109.